Zealand Pharma

Director's Dealing • May 28, 2021

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Matthew Donald Dallas
2.		Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amend ment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc tion monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instru ment	Restricted Share Units
	Identification code	DK0060257814
b)	Nature of the transaction	Allocation of Restricted Share Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 191,6	11.517
d)	Aggregated information - Aggregated volume - Price	DKK 2.206.657,20
e)	Date of the transaction	27 May 2021
f)	Place of the transaction	Outside trading venue